Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Dr Lal PathLabs’ shares sank over four percent intraday on Monday, April 28. While the medical diagnostic centre reported a steady March quarter, brokerages had a mixed outlook for the current quarter ...

Discover Dr Lal Path Labs diagnostic services in Gurgaon, Haryana. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

(Reuters) - Dr. Lal PathLabs, India's top diagnostics firm by revenue, reported a bigger-than-expected second-quarter profit on Wednesday, driven by continued demand and a rising awareness for health ...

Earnings call Dr. Lal PathLabs reported Q2 FY26 revenue of ₹731 crore, up 10.7% YoY, with PAT rising 16.4% to ₹152 crore and EBITDA margin stable at 30.7%. Management reaffirmed FY26 revenue growth ...